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Background: This study described altered platelet indices in patients with acute malaria caused by Plasmodium
vivax and determined whether these alterations are associated with warning signs of severe and complicated
malaria.
Methods: A total of 186 patients attending the Malaria Clinic at the University Hospital from the Federal University
of Mato Grosso, Brazil, between 2008 and 2013 were included in this study. After parasitological confirmation of
exclusive infection by P. vivax, blood cell counts and platelet indices were determined. Disease gravity was
evaluated on the basis of classic signs of Plasmodium falciparum severe malaria, including severe anemia, or by
changes in serum levels of glucose, bilirubin, aminotransferases and creatinine at the time of the patient’s
admission. Patients with a longer duration of symptoms or those identified as primo infected were considered
potential candidates for evolution into the severe form of malaria.
Results: The mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) values exhibited
significant variability. A significant inverse relationship was observed between parasitaemia and PCT. Patients with
warning signs for evolution into severe disease, with primo infection, or presenting with symptoms for over three
days had the highest MPV and PDW. The adjusted analyses showed the presence of warning signs for the
development of severe and complicated malaria remained independently linked to elevated MPV and PDW.
Conclusion: Altered platelet indices should be analysed as potential markers for the severity of malaria caused by
P. vivax. Future studies with appropriate methodology for prognostic evaluation could confirm the potential use of
these indices in clinical practice.
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Several clinical complications have been described in
malaria caused by Plasmodium vivax, including severe
anaemia, cerebral malaria, acute pulmonary oedema, and
multi-organ failure [1]. Although thrombocytopaenia is
often reported, the occurrence of bleeding is rare in these
patients [2].* Correspondence: alexandre3025@gmail.com
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article, unless otherwise stated.Changes in platelet counts during acute malaria are
commonly reported in the medical literature, especially
in Plasmodium falciparum infections; such changes are a
major cause of concern to clinicians because such cases are
more likely to evolve into serious and complicated disease
cases [3,4]. However, many recent studies have also found
thrombocytopaenia associated with P. vivax [5-7]. In
general, the underlying mechanisms of thrombocytopaenia
in malaria are peripheral destruction, excessive sequestra-
tion of platelets in spleen, and excessive use of platelets
associated with the disseminated intravascular coagulationtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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number of platelets, platelet function is also compromised
in these patients; this is generally evidenced by changes in
the volume and other features of platelet cells [9].
Moreover, in addition to their function in haemostasis,
platelets play an important role in the inflammatory
response [10]. Changes in platelet counts during bacterial
infections are reported to be associated with enhanced
disease severity and mortality [11]. Furthermore, platelet
activation alters the morphology of these cells, which can
be evaluated on the basis of mean platelet volume (MPV)
and platelet distribution width (PDW) [12]. Another
platelet parameter is plateletcrit (PCT), which is a reliable
measurement of platelet biomass because it combines the
MPV with the absolute platelet count [13]. MPV, PDW and
PCT can be altered in patients with cardiovascular [13] and
infectious diseases such as pulmonary tuberculosis [14].
All of these indices are considered markers of platelet
activation [9,15] and are altered in different clinical
conditions [16-18]. Nevertheless, little is known about
the alterations in these indices in malaria, especially
in infections with P. vivax.
Some studies reported MPV to be elevated in malaria
[4,19,20]. Furthermore, the validity of this finding for the
diagnosis of acute malaria was recently tested in suspected
cases in India [21]. However, the relationship between
this increase and the clinical outcome of malaria infection
remains controversial [19,22]. Furthermore, there is no
available information about the relationship between
altered PDW or PCT and the severity of malaria caused by
P. vivax.
The present study aimed to determine the frequency
and factors associated with alterations in platelet indices
in patients with malaria caused by P. vivax, as well as
their associations with clinical and laboratory indicators
of severe and complicated malaria outcomes.
Methods
This is a cross-sectional descriptive study based on the
clinical and laboratory data of 186 patients with acute
malaria caused by P. vivax who attended the Malaria
Clinic at the University Hospital of the Federal University
of Mato Grosso between 2008 and 2013. Data were
collected on both ways: on a standardized form from
50 patients and extracted from the records of the
remaining ones. Patients with exclusive P. vivax infection
were eligible to participate in this study. All the patients
underwent haemogram and blood biochemical analyses
at their first appointment. Malaria was diagnosed on the
basis of the microscopic examination of Giemsa-stained
thick smears. All blood cell counts were determined
using a same automated equipment (Pentra 80; Horiba
Medical, Montpellier, France), which provides results
regarding MPV, PDW, and PCT. The normal rangesfor MPV, PDW and PCT provided for this equipment
are 7.0/μm3-10.5/μm3, 11%-18% and 0.15%-0.50%,
respectively.
Blood samples were continuously agitated after collection.
To avoid interference in the analysed parameters, the time
between blood sample collection and cell counting was
ensured to be shorter than 60 minutes. All the participants
signed an informed consent and underwent a detailed
clinical evaluation by a team physician prior to participating.
Information about the number of previous malaria
infections and time of symptom onset was collected
from all the patients.
Potential severe and complicated malaria caused by
P. vivax was defined by the presence of one or more
of the classic signs used as predictors of P. falciparum
severity recommended by the World Health Organization
[23] or the following changes in blood haematology or
biochemical parameters at the time of patient’s admission:
body temperature ≥41°C, dyspnoea, arterial hypotension,
serum creatinine level >1.5 mg/dL, hypoglycaemia,
hyperbilirubinaemia and haemoglobin <7 g/dL or haem-
atocrit <20%. Moreover, primo infection and reporting
symptoms that persisted for longer than three days were
also considered potential risk factors for evolution into
severe disease.
The data were analysed by the Stata version 12 software.
The Mann-Whitney non-parametric test was used to
analyse the association between platelet indices with
the presence/absence of markers for severe or complicated
malaria caused by P. vivax. Spearman’s correlation coeffi-
cients were calculated to evaluate the relationships between
platelet indices and parasitaemia. Multivariate logistic
regression models were constructed with each parameter
as a dependent variable to analyse the independence of
the associations between severity and platelet indices.
For this purpose, MPV, PDW, and PCT were strati-
fied into two groups, namely above and below the
median. The reason to use these strata was the large
range of the normal platelet indices. The backward
stepwise method was used to include all the studied
variables in the model. The level of significance was
set at p <0.05. This study was approved by the Research
Ethics Committee of Julio Müller University Hospital
(no. 242,721).
Results
The patients had a median age of 37,5 years and mean
(SD) of 37.7 (14.7) years, and 145 (78.0%) were men. The
elapsed time between symptom onset and the diagnosis of
malaria ranged from one to 60 days (median = 5 days),
with a mean (SD) of 7.1 (8.6) days. However, malaria was
only diagnosed after 96 hours (i e, four days after symptom
onset) in 54.4% of patients. At the time of diagnosis, 56.1%
of the patients had fever. Twenty-one patients (11.3%) had
Table 1 Clinical and laboratory characteristics of patients
with malaria caused by Plasmodium vivax
Characteristics n %
Age (years) (n = 182) 0-12 5 2.7
13-49 139 76.4
≥50 38 20.9
Mean (SD), 37.7 (14.7)
Sex Male 145 78.0
Female 41 22.0
Days with symptoms (n = 167) 1 18 10.8
2-4 58 34.7
>4 91 54.5
Mean (SD), 7.1 (8.6)
Fever at diagnosis (n = 157) Yes 88 56.1
No 69 43.9
Indication of severity Yes 21 11.3
No 165 88.7
Parasitaemia/mm3 (n = 172) Mean (SD), 7,256 (11,147)
Variation in the numbers of individuals is due to missing information.
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malaria, including hyperpyrexia, severe anaemia, arterial
hypotension, and elevated serum creatinine. The mean
parasitaemia level observed in 186 patients was 7,256
(11,147) parasites per mm3 blood (median = 4,186). No
patient reported using medicines with the potential to
interfere with platelet indices (Table 1).
The haematological evaluation of all the patients
showed a mean haemoglobin level of 12.9 (2.0) g/dL,
mean haematocrit level of 38.5% (5.5%), and mean
leukocyte count of 6,278 (6,323) leukocytes/mm3. The
mean platelet count was 114,823 (76,761) cells/mm3; 16.7




First infection Yes 9.77
No 9.09
p 0.00
Time of symptom onset >3 days 9.32
≤3 days 9.12
p 0.16
Warning signs for severity Present 9.62
Absent 9.21
p 0.04
p values were calculated according to the Mann-Whitney test.50,000/mm3 and between 50,000/mm3 and 150,000/mm3,
respectively. The MPV was 9.3 (1.0) μm, mean PDW was
17.5% (3.36%), and mean PCT was 0.104% (0.066%). All
the blood haematological parameters were done in a same
automatic equipment.
Potentially more serious cases, that is, primo-infected
patients, exhibited significantly higher MPV and PDW
(p = 0.0003 and p = 0.0003, respectively) and signs of
gravity (p = 0.042 and p = 0.036, respectively). Conversely,
patients with three or more days of symptoms had lower
PCT (p = 0.045; Table 2). A weak but statistically significant
negative correlation was observed between parasitaemia
and PCT (r = -0.28; p = 0.0002). However, no significant
correlation was observed between parasitaemia and MPV
or PDW (Figure 1).
Adjusted models were constructed for each platelet
parameter, which were categorized as higher or lower
the median. Variables exhibiting significant associa-
tions in the univariate analysis were included in the
model in addition to age and sex. After adjustments,
primo infection and the presence of warning signs for
severe malaria were independently associated with the
highest MPV. Conversely, PDW remained associated
with the number of previous malaria infections and
the presence of signs of gravity. Only the longest dur-
ation of symptoms remained associated with the lowest
PCT (Table 3).
Discussion
In the present study, the analysis of the platelet indi-
ces in 186 patients with malaria caused by P. vivax
revealed a high frequency of thrombocytopaenia and
changes in MPV, PDW, and PCT. The high fre-
quency of warning signs of severe malaria cases can
be explained by the fact that this study was con-
ducted in a reference hospital for malaria diagnosis
and treatment.s of severity in the patients with Plasmodium vivaxmalaria
telet parameter
an (SD)
V (per μm3) PDW (%) PCT (%)
(0.98) 19.87 (4.61) 0.086 (0.046)
(0.94) 16.85 (2.89) 0.102 (0.053)
03 0.0003 0.1165
(1.03) 17.93 (3.75) 0.091 (0.055)
(0.86) 16.77 (2.81) 0.104 (0.044)
6 0.065 0.045
(1.12) 18.98 (3.64) 0.079 (0.036)
(0.95) 17.35 (3.46) 0.105 (0.067)
2 0.036 0.084
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Figure 1 Relationships between parasitic density and other variables in the patients with malaria caused by Plasmodium vivax. Parasitic
density versus MPV (A), PDW (B), and PCT (C).
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the patients, which is a higher percentage than that
observed in patients infected with P. falciparum
(25%) in Saudi Arabia [24] but similar to that re-
ported by Franklin et al. [6] and Coelho et al. [20]
regarding patients infected with P. vivax in the Amazon
region. Increased MPV in malaria has been observed in
other studies [4,19]. The validity of using such an increase
in MPV in the diagnosis of acute malaria in suspected
cases was recently tested in India; the authors concluded
that a MPV exceeding 8 μm3 exhibits a sensitivity and
specificity of 70.8 and 50.4% for the diagnosis of malaria,
respectively [21].
It is well known that non-immune individuals are
more susceptible to developing severe malaria. Further-
more, the delay of onset of malaria treatment is directly
associated with severe disease outcomes [23]. In this
study, changes in platelet indices predominated in the
patients with any indicator of severe malaria caused by
P. vivax, such as primo infection, longer symptom dur-
ation, and the presence of clinical signs and laboratory
indicators of severe malaria. Larger platelets are meta-
bolically and enzymatically more active and have a more
important role in the inflammatory process [25]. Ele-
vated MPV has also been described in patients with
severe sepsis and is explained by the quick splenic
and medullary release of large volumes of platelets in
response to the increased demand for these cells [16].
In fact, studies in humans and rats showed that large
platelets are functionally more active and have a lowerthreshold for aggregation and the release of their activity
[9,16]. In bacterial diseases, increased MPV is associated
with invasive infection or refractoriness to antimicrobial
treatment [26].
It is well known that PDW is linearly correlated
with MPV in normal individuals [12]. However, it is
unlikely that the increased PDW observed in the
present study was solely a consequence of increased
MPV. Platelet width is reported to be greatly heterogeneous
even with normal MPV in myeloproliferative diseases
[12], eclampsia [27], acute coronary syndrome and
heart failure [28], vascular micro-occlusion of sickle-cell
disease [29], and bacteraemia [9,16,26]. Only one study
mentions MPV in malaria and concluded that this param-
eter can be considered a predictor of acute infection
by P. falciparum [21]. In all of these studies, the
platelet activation was considered the main mechanism
inducing the elevation of MPV and PDW.
Low mean PCT was also verified in the patients
with acute malaria in the present study. However, little is
known about PCT during the courses of various diseases.
Thus, PCT is the most neglected haematological param-
eter in clinical practice and one of the least often reported
in publications in the biomedical literature. PCT alter-
ations are observed in some clinical conditions such
as coronary ischemia [13], diabetes mellitus [30], pulmon-
ary tuberculosis [31], sleep apnea [32], and inflammatory
bowel disease [33].
The preference of P. vivax for infecting only young
cells in peripheral blood avoids the occurrence of high
Table 3 Multivariate logistic regression analysis of the
associations between platelet indices, demographic
variables, and severity indicators
Variable Odds ratio 95% CI p
MPV
Primo infection 2.72 1.16-6.38 0.039
Presence of warning signs for severity 3.47 1.02-11.75 0.033
PDW
Previous episodes of malaria 0.91 0.85-0.97 0.004
Presence of warning signs for severity 5.44 1.20-24.78 0.028
PCT
Time with symptoms (days) 2.46 1.11-5.46 0.038
Variables showing p ≤0.20 in the univariate analysis were included in the
model in addition to age and sex.
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found a negative correlation between the level of parasit-
aemia and PCT. Once the PCT is a measure of the
platelet biomass, this finding may be explained by the
concomitant thrombocytopenia, which is also known to
be associated with thrombocytopenia associated with
P. vivax infections [35,36].
This study has some limitations that should be
mentioned. First, other conditions causing platelet
count reduction and changes in platelet indices were
not systematically investigated. However, the changes
in the studied parameters as part of post-treatment
evaluation suggest that malaria was the most likely
cause of the observed alterations.
Conclusion
In conclusion, this study shows that platelet indices
were altered during acute and symptomatic infection
by P. vivax. The elevation of MPV and PDW, and re-
duction of PCT are related to known potential risk
factors for evolution into severe malaria, such as
primo infection, longer symptom duration, and the
presence of the classical warning signs of severe and
complicated P. falciparum malaria. Therefore, these
parameters and indices could be useful as predictors
of severity in the clinical approach of patients with malaria
caused by P. vivax. Nevertheless, studies with appropriate
methodology to measure prognostic outcomes are
required to confirm the efficacy of these indices in clinical
practice.
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